Simplex Trading, LLC I Teos Therapeutics, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$10.33 - $18.09 $166,137 - $290,941	16,083 New	16,083 $238,000
Q4 2023 Feb 02, 2024	BUY	$8.57 - $11.06 $55,070 - $71,071	6,426 New	6,426 $70,000
Q2 2023 Aug 04, 2023	BUY	$12.93 - $18.05 $122,356 - $170,807	9,463 Added 463.87%	11,503 $152,000
Q1 2023 Apr 27, 2023	SELL	$13.02 - $22.62 $4,986 - $8,663	-383 Reduced 15.81%	2,040 $27,000
Q4 2022 Feb 02, 2023	BUY	$17.77 - $21.6 $41,777 - $50,781	2,351 Added 3265.28%	2,423 $47,000
Q3 2022 Nov 04, 2022	SELL	$18.6 - $27.25 $207,073 - $303,374	-11,133 Reduced 99.36%	72 $1,000
Q2 2022 Aug 03, 2022	BUY	$16.57 - $35.1 $185,666 - $393,295	11,205 New	11,205 $230,000

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.